The Gut Microbiome and Autoimmune Diseases: Harnessing Regulatory T Cells for Immune Reset
Building on the Nobel Prize-winning discovery of Regulatory T Cells, 2026 research focuses on harnessing the gut microbi...
Read More →Building on the Nobel Prize-winning discovery of Regulatory T Cells, 2026 research focuses on harnessing the gut microbi...
Read More →Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie ...
Read More →Neuralink has received FDA Breakthrough Device Designation for its speech restoration BCI technology, aiming to translat...
Read More →GLP-1 medications in 2026 are transforming from weight-loss drugs to essential cardiovascular and renal therapies. With ...
Read More →Moderna and Merck's 5-year follow-up data for the personalized mRNA cancer vaccine intismeran autogene shows a sustained...
Read More →The 2026 Alzheimer's pipeline features 192 clinical trials, highlighted by the FDA approval of subcutaneous Leqembi and ...
Read More →The CRISPR clinical landscape in 2026 has expanded to over 250 active trials, moving beyond sickle cell disease into in ...
Read More →The C2PA 3.0 mandate requires all commercial generative AI to implement latent space watermarking and cryptographic prov...
Read More →An AI-driven materials science platform has discovered and verified a novel ternary hydride compound that exhibits super...
Read More →Intel and IBM have begun mass production of commercial neuromorphic computing chips, utilizing Spiking Neural Networks (...
Read More →Toyota and QuantumScape have achieved a massive solid-state battery breakthrough, utilizing a novel sulfide electrolyte ...
Read More →The AI industry is shifting from passive LLMs to active "Agentic" AI systems, with multi-agent reinforcement learning (M...
Read More →